Latest Blog Posts Tagged "Thought Leadership"
October 25, 2018
'Forbes' published a story detailing a 'milestone moment' in the history of LRRK2 and role of the Foundation in ushering this promising genetic target forward.
May 31, 2018
At MJFF, we are investing tens of millions of dollars in genetic research. But how does a genetic finding become a direction to a new treatment?
December 07, 2017
Todd Sherer, PhD, penned an op-ed for 'The Hill' that called out the need for a national plan to fuel PD research and breakthroughs.
November 14, 2017
The Sherer Report from the Fall/Winter 2017 edition of The Fox Focus, our biannual newsletter.
August 23, 2016
A recent editorial from MJFF and J. William Langston, MD, outlines a strategy to develop targeted treatments that could prevent, slow or stop Parkinson's progression.
July 18, 2016
MJFF's Katie Kopil, PhD, offers her insights on how scientists can pursue non-traditional research careers to help patients.
October 06, 2015
"The road to a cure is not a straight line."
November 18, 2014
Our CEO Todd Sherer, PhD, recently spoke with trade publication The Pink Sheet about progress in Parkinson's disease research and the Foundation's de-risking model.
November 10, 2014
This summer we asked people with Parkinson's to take a survey on the impact of "off" episodes. The results are part of discussions MJFF is leading with groups that make medication coverage decisions.
September 26, 2014
MJFF is working with insurance companies and Medicare/Medicaid to share information on patient needs and payer priorities to help new Parkinson's therapies secure coverage.